Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex, Phenomenex Team on Food Safety Venture

NEW YORK (GenomeWeb News) – AB Sciex said today that it has partnered with Phenomenex to combine their respective mass spectrometry and sample prep offerings for integrated food safety testing services.

Under the pact, Phenomenex will work with AB Sciex to expand and sell the AB Sciex iMethod applications and to combine the Phenomenex HPLC/UHPLC columns and sample preparation with AB Sciex's mass spectrometers. The aim is to create combined solutions for simplifying and accelerating the testing process for addressing food contamination crises.

The companies also have created a joint rapid response team for developing methods to support testing services for pesticides, antibiotics, allergens, and natural toxins, to labs worldwide. This joint unit includes personnel from Phenomenex's method development research team and AB Sciex's total solutions group.

AB Sciex also said that it has been developing an iMethod application to improve identification and quantitation of shellfish toxins in the food supply with a researcher at the National Research Council of Canada.

"Not only are we combining state-of-the-art sample preparation, chromatography and mass spectrometry, but we are also providing the opportunity for any lab in the world to access the ingenuity of leading experts in food safety analysis through our joint rapid response team," Sky Countryman, manager of the Phenomenex applied markets research team, said in a statement.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.